GSK3685032 10 mg | ≥98% Cayman Chemical A DNMT1 inhibitor More Information Supplier Page × GSK3685032
2’-O-MOE-U-3’-phosphoramidite 500 mg | ≥98% Cayman Chemical A nucleoside building block More Information Supplier Page × 2’-O-MOE-U-3’-phosphoramidite
2’-O-MOE-U-3’-phosphoramidite 250 mg | ≥98% Cayman Chemical A nucleoside building block More Information Supplier Page × 2’-O-MOE-U-3’-phosphoramidite
Rezatapopt 5 mg | ≥98% Cayman Chemical A reactivator of p53Y220C More Information Supplier Page × Rezatapopt
2’-O-MOE-U-3’-phosphoramidite 1 g | ≥98% Cayman Chemical A nucleoside building block More Information Supplier Page × 2’-O-MOE-U-3’-phosphoramidite
Rezatapopt 25 mg | ≥98% Cayman Chemical A reactivator of p53Y220C More Information Supplier Page × Rezatapopt
Rezatapopt 10 mg | ≥98% Cayman Chemical A reactivator of p53Y220C More Information Supplier Page × Rezatapopt
DMTr-LNA-G(iBu)-3’-CED Phosphoramidite 500 mg | ≥98% Cayman Chemical A nucleoside building block More Information Supplier Page × DMTr-LNA-G(iBu)-3’-CED Phosphoramidite
